{"id":267440,"date":"2026-09-24T12:31:40","date_gmt":"2026-09-24T07:01:40","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=267440"},"modified":"2026-09-24T12:31:40","modified_gmt":"2026-09-24T07:01:40","slug":"brooks-laboratories-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/brooks-laboratories-best-stock-in-its-sector\/","title":{"rendered":"Is Brooks Laboratories the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Brooks Laboratories CMP Rs 61 (24 Sep 2026). Market cap Rs 180 Cr. ROE 4.80%. P\/E 39.53x versus Industry P\/E 51.57x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Brooks Laboratories is one of the names investors compare when screening the Healthcare sector, built on a 4.80% return on equity and a P\/E of 39.53x against an Industry P\/E of 51.57x. Whether Brooks Laboratories is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Brooks Laboratories<\/a> the best stock in its sector? The stock trades on the NSE at Rs 61 as of 24 September 2026, within its 52-week range of Rs 36.30 to Rs 152.39. Brooks Laboratories Ltd manufactures sterile injectable and ophthalmic pharmaceutical formulations.<\/p>\n

Brooks Laboratories sits in the Healthcare sector, and its 4.80% ROE and 39.53x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n